Thromboembolism Industry Pipeline Review, H1, Growth, Analysis, Forecast 2015 - PowerPoint PPT Presentation

Loading...

PPT – Thromboembolism Industry Pipeline Review, H1, Growth, Analysis, Forecast 2015 PowerPoint presentation | free to download - id: 73662d-ZWUzZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Thromboembolism Industry Pipeline Review, H1, Growth, Analysis, Forecast 2015

Description:

Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thromboembolism and special features on late-stage and discontinued projects. Read the Complete Report @ – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Thromboembolism Industry Pipeline Review, H1, Growth, Analysis, Forecast 2015


1
Thromboembolism - Pipeline Review, H1 2015
Industry Size, Share, Global Trends, Company
Profiles, Demand, Insights, Analysis, Research,
Report, Opportunities, and Forecast 2015
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
2
Report overview
Research Beam adds a report titled
"Thromboembolism - Pipeline Review, H1 2015". The
report provides an in-depth study on the
Thromboembolism Industry Analysis, opportunities
and factors influencing the market. Summary Globa
l Markets Directs, Thromboembolism - Pipeline
Review, H1 2015, provides an overview of the
Thromboembolisms therapeutic pipeline. This
report provides comprehensive information on the
therapeutic development for Thromboembolism,
complete with comparative analysis at various
stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of
administration (RoA) and molecule type, along
with latest updates, and featured news and press
releases. It also reviews key players involved in
the therapeutic development for Thromboembolism
and special features on late-stage and
discontinued projects. Global Markets Directs
report features investigational drugs from across
globe covering over 20 therapy areas and nearly
3,000 indications. The report is built using data
and information sourced from Global Markets
Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. The
report enhances decision making capabilities and
help to create effective counter strategies to
gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class products.

3
Report overview
Scope - The report provides a snapshot of the
global therapeutic landscape of Thromboembolism -
The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players
involved in the therapeutics development for
Thromboembolism and enlists all their major and
minor projects - The report summarizes all the
dormant and discontinued pipeline projects - A
review of the Thromboembolism products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources - Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages - A detailed
assessment of monotherapy and combination therapy
pipeline projects - Coverage of the
Thromboembolism pipeline on the basis of target,
MoA, route of administration and molecule type -
Latest news and deals relating related to
pipeline products

4
Report overview
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Thromboembolism - Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline - Devise
corrective measures for pipeline projects by
understanding Thromboembolism pipeline depth and
focus of Indication therapeutics - Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and scope - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire about report _at_
http//www.researchbeam.com/thromboembolism-pipeli
ne-review-h1-2015-market/enquire-about-report

5
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/thromboembolism-pipeli
ne-review-h1-2015-market
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
Stay With Us
About PowerShow.com